Mrgprb2-KO mice have been reported to have significantly reduced inflammation, including itching in various models of allergic contact dermatitis [97,98,99], suggesting that MRGPRX2 is involved in the development of ACD as well as atopic dermatitis. Here, MRGPRX2 is linked to granular corneal dystrophy type II.